What is Addifab?
Addifab is at the forefront of revolutionizing the injection molding industry. Leveraging deep market insights and ambitious goals, the company has pioneered a unique soluble mold tooling technology that enables Freeform Injection Molding. Their established Print-Inject-Dissolve process liberates design and material constraints, allowing for the creation of unprecedented designs, products, and business opportunities at remarkable speeds.
How much funding has Addifab raised?
Addifab has raised a total of $6.3M across 1 funding round:
Other Financing Round
$6.3M
Other Financing Round (2021): $6.3M with participation from West Hill Capital
Key Investors in Addifab
West Hill Capital
West Hill Capital is an investment firm that likely focuses on providing capital to companies with strong growth potential, potentially within the industrial or manufacturing sectors, given their involvement with Addifab.
What's next for Addifab?
With a substantial enterprise-level funding injection, Addifab is poised for accelerated growth and market penetration. The strategic investment will likely fuel further research and development into their innovative soluble mold tooling technology, expanding manufacturing capabilities, and broadening their market reach. This capital infusion signals a strong confidence in Addifab's disruptive approach to injection molding and its potential to redefine industry standards.
See full Addifab company page
